Appropriate management of cutaneous adverse events maximizes compliance with sorafenib treatment: a single-center experience

Author: Scandurra Giuseppa   Aiello Rosa Anna   Alì Marco   Taibi Eleonora   Sanò Maria Vita   Todaro Francesco Maurizio   La Rocca Rosaria   Licciardello Paolo   Caruso Michele  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.8, Iss.5, 2012-05, pp. : 609-615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content